previous compound ID: 546 next compound
InChIKey: FAEKWTJYAYMJKF-QHCPKHFHSA-N
SMILES: CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "JW Hanrahan" "DY Thomas" "GW Carlile" "B Kus" "R Robert" "J Liao" "E Matthes" "D Rotin" "SD Macknight"

chemical graph of compound 546





CID is 65981
synonyms found at PubChem are:
Repaglinide, 135062-02-1, Prandin, NovoNorm, GlucoNorm, AG-EE 623 ZW, Repaglinidum, Repaglinida, Repaglinidum [INN-Latin], Repaglinida [INN-Spanish], AG-EE 388 ZW, (S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid, AGEE-623ZW, Repaglinide [USAN], Actulin, Surepost, Prandin (TN), UNII-668Z8C33LU, AG-EE 388, CHEMBL1272, Repaglinide (JAN/USP/INN), (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid, AG-EE-623 ZW, CHEBI:8805, AG-EE-388, SMP-508, 668Z8C33LU, C27H36N2O4, NN-623, (S)-2-ethoxy-4-(2-(3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoic acid, 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid, 2-Ethoxy-4-[2-[[(1S)-3-Methyl-1-[2-(1-Piperidinyl)Phenyl]Butyl]Amino]-2-Oxoethyl]Benzoic Acid, NCGC00016978-01, 111GE012, CAS-135062-02-1, (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid, (S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid, 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid, (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid, Q-201663, (-)-Repaglinide, Reglin, repa-glinide, 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid, 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid, 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid, Benzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-, (S)-, SMR000466305, repaglinide, (+-)-isomer, enyglid, (S)-Repaglinide, Repaglinide,(S), GlucoNorm (TN), Surepost (TN), (S)-2-Ethoxy-4-[2-[[3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid, Repaglinide [USAN:USP:INN:BAN], NovoNorm (TN), (S)-(+)-Repaglinide, AC1Q5TZW, Prestwick0_001046, Prestwick1_001046, Prestwick2_001046, Prestwick3_001046, DSSTox_CID_3552, Prandin;GlucoNorm;NovoNorm, D0N5YA, DSSTox_RID_77078, DSSTox_GSID_23552, SCHEMBL16137, BSPBio_000972, MLS000759407, MLS001076684, MLS001424111, MLS006011560, AG-EE 623ZW, BIDD:GT0338, SPBio_002906, AC1L24D5, BPBio1_001070, GTPL6841, DTXSID3023552, CTK3J7345, Novo Nordisk brand of repaglinide, FAEKWTJYAYMJKF-QHCPKHFHSA-N, MolPort-003-850-140, HMS1571A14, HMS2051N08, HMS2094C07, HMS2098A14, HMS2231M21, HMS3715A14, Pharmakon1600-01506035, Glaxo Wellcome brand of replaginide, BCP04250, KS-00000GU9, ZINC3798537, Novo Nordisk brand 2 of repaglinide, Tox21_110721, AC-726, ANW-63956, BDBM50153520, BG0514, MFCD00906179, NSC759893, s1426, STK629501, AKOS005561792, Repaglinide, >=98% (HPLC), solid, API0004049, BS-1010, CCG-101013, CS-0979, DB00912, MCULE-3611790330, NC00263, NSC-759893, RTC-063882, NCGC00016978-02, NCGC00016978-04, NCGC00016978-05, AJ-45642, AK-59609, AN-15576, BC220160, CC-34234, CPD000466305, HY-15209, I979, LS-38509, SAM001246546, SC-17344, Prandin, GlucoNorm, NovoNorm, Repaglinide, SBI-0206942.P001, AB0013959, AB2000099, AX8145505, TC-063882, AB00514019, AM20090697, FT-0631150, R0179, ST24036034, 62R021, C07670, D00594, W-5210, AB00514019-09, AB00514019_10, AB00514019_11, C-22512, SR-01000759404, SR-01000759404-4, BRD-K82846253-001-03-0, Z1777729210, Repaglinide, European Pharmacopoeia (EP) Reference Standard, Repaglinide, United States Pharmacopeia (USP) Reference Standard, (s)-(+)-2-ethoxy-4-(2-oxo-2-[(alpha-isobutyl-2-piperidinobenzyl)amino]ethyl)-benzoic acid, Repaglinide for system suitability, European Pharmacopoeia (EP) Reference Standard, (S)-2-Ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid, 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid, 2-Ethoxy-4-{[(S)-3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid, Benzoic acid, 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-